drugset
drugset / Trial / NCT07628049

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

NCT07628049 ↗

Phase 1/2 Recruiting 1808 enrolled GlaxoSmithKline
RandomizedSequentialQuadruple-blindPrevention

Summary

The aim of this study is to evaluate the safety, reactogenicity, and immune response of the different formulations of the investigational RSV/hMPV combination vaccine and investigational hMPV vaccine in younger and older adults.

Timeline

Start
2026-06-05
Primary completion
2029-04-05
Completion
2029-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject RSV/hMPV\_V Vaccine — Intramuscular
Subject RSV/hMPV\_W Vaccine — Intramuscular
Subject RSV/hMPV\_X Vaccine — Intramuscular
Subject hMPV\_Y Vaccine — Intramuscular
Subject hMPV\_Z Vaccine — Intramuscular

Indications

Mononegavirales infectious disease